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Background: It has been postulated that disruption of the mitral valve apparatus at 
the time of mitral valve replacement (MVR) is a risk factor for postoperative 
ventricular dysfunction. The aim of this study was to evaluate the effect of single 
versus bilateral chordo-papillary preservation on the left ventricular function in 
comparison to no preservation. 
Methods: This study was conducted from 2015 to 2018 on sixty patients who had 
MVR. The patients were classified into group I included 20 patients who underwent 
MVR with complete excision of the subvalvular chordae and tips of papillary 
muscles, group II: included 20 patients who underwent MVR with preservation of 
posterior chordo-papillary apparatus, and group III: included 20 patients who 
underwent MVR with preservation of both posterior and anterior chordo-papillary 
apparatus.  
Results: There were 20 males (33.3%), and the mean age was 48.76± 8.91 years. 
Patients in group III were significantly older (37.15 ±4.92, 39.8 ± 5.49, and 57.25 ± 
6.93 years in groups I, II, and III, respectively; p< 0.001). The left ventricular end-
diastolic (5.40 ±0.34, 4.96 ± 0.43, and 4.44 ± 0.55 mm in group I, II and III, 
respectively, p<0.001) and end-systolic diameter (4.33 ±0.48, 3.58 ±0.43 and 3.20 
±0.43 mm in group I, II and III; respectively, p<0.001) were significantly reduced in 
partial and complete preservation groups after 6 months. Left ventricular ejection 
fraction improved in the bilateral preservation and partial preservation groups after 
6 months (45.32 ±9.78, 56.79 ±10.14, and 56.60 ±11.68 % in groups I, II and III 
respectively, p<0.001). Mechanical ventilation was significantly longer in group I 
(24.10 ± 6.6, 16.80 ± 5.97, and 15.80 ± 5.24 hours in groups I, II and III, respectively, 
p<0.001) and the duration of ICU stay was significantly longer in group I (78.65 ± 
15.32, 65.40 ± 14.21, and 60.20 ± 12.58 hours in groups I, II and III, respectively, 
p<0.001). 
Conclusion: Preservation of the annulo-papillary continuity may preserve left 
ventricular geometry and performance. Total preservation of chordae could be 
superior to partial preservation with better left ventricular remodeling and 
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Introduction 
Mitral valve repair is the preferred method 
for management for mitral valve diseases [1]; 
however, the repair is not feasible in all patients 
[2]. Complete excision of the mitral valve 
apparatus was associated with an increased 
incidence of low cardiac output and high 
morbidity and mortality [3]. Subsequently, 
several strategies were implemented to improve 
postoperative outcomes, including sub-valvular 
apparatus preservation (SVP) [4]. 
The outcomes of complete versus partial 
preservation of the mitral valve apparatus varied 
widely in the literature. [5-8]. Lillehei and 
associates reported lower operative mortality and 
morbidity with valvular preservation compared to 
no leaflet preservation [9]. Complete chordal 
preservation during mitral valve replacement 
(MVR) may have an advantage through the 
reduction of the left ventricular size and 
maintenance of the ejection fraction [10]. 
Meanwhile, several studies showed equivalent 
outcomes with complete and partial preservation 
of the mitral valve apparatus [11].  
Therefore, the objective of the current study 
was to compare the clinical and echocardiographic 
outcomes after mitral valve replacement with 
bilateral leaflet preservation, posterior leaflet 
preservation, and non-leaflet preservation 
techniques. 
Patients and Methods: 
Study design and patients 
This prospective cohort study recruited 60 
consecutive patients who had mitral valve 
replacement (MVR) between December 2015 and 
December 2018, at Nasr City Health Insurance 
Hospital. The Ethical Committees approved the 
study protocol, and informed consent was 
obtained from all patients. Patients who had re-
operative MVR or MVR for valve endocarditis, and 
patients with a concomitant procedure (aortic 
valve replacement, tricuspid valve surgery, 
coronary artery bypass grafting) were excluded 
from the study. 
There were 20 males (33.3%), and the ages 
ranged from 28 to 66 years with a mean ± SD of 
48.76± 8.91 years. The demographic and clinical 
profile of the patients is shown in table 1. Patients 
in group III were significantly older than group I 
and II, and no statistically significant difference 
was found between them regarding gender.  
All patients presented with dyspnea classified 
according to the New York Heart Association 
(NYHA) classification grade III and IV. There is no 
significant difference between the mean values 
of NYHA classes in the three groups (p=0.552) 
(Table 1) 
Table 1: Demographic data of the study population grouped according to valve preservation strategy during mitral 
valve replacement. Categorical data are presented as number and percent and continuous data as mean and standard 
deviation. 
Group I (n=20) Group II (n=20) Group III (n=20) P-value P1 P2 P3 
Age (years) 37.15 ±4.92 39.8 ± 5.49 57.25 ± 6.93 <0.001 0.157 <0.001 <0.001 
Females 14 (70.0%) 15 (75.0%) 11 (55.0%) 0.377 - - - 
BMI (Kg/m) 1.74 ± 0.09 1.92 ± 0.14 1.95 ± 0.16 <0.001 <0.001 <0.001 0.372 
Diabetes mellitus 3 (15.0%) 4 (20.0%) 1 (5.0%) 0.364 - - - 
Hypertension 3 (15.0%) 4 (20.0%) 2 (10.0%) 0.676 - - 
COPD 1 (5.0%) 2 (10.0%) 2 (10.0%) 0.804 - - - 
AF 9 (45.0%) 9 (45.0%) 6 (30.0%) 0.535 - - - 
NYHA class 2.90 ± 0.64 3.10 ± 0.55 3.05 ± 0.61 0.552 - - - 
AF: atrial fibrillation; BMI: body mass index; COPD: chronic obstructive lung disease, NYHA: New York Heart 
Association 
P1: comparison between group I and III  
P2: comparison between group II and III 




Table 2: The native valve pathology and baseline echocardiographic data in the three groups. (Continuous variables 
are presented as mean± SD and categorical data as number and percent) 
Group I (n=20) Group II (n=20) Group III (n=20) P-value P1 P2 P3 
Mitral valve pathology 
Mitral stenosis 5 (25.0%) 3 (15 %) 8 (40.0%) 
0.001 0.137 < 0.001 0.001 Mitral regurge 3 (15.0%) 8 (40%) 12 (60.0%) 
Mixed lesion 12 (60.0%) 9 (45%) 0 
Rheumatic 18 (90 %) 15 (75%) 8 (40.0%) 
0.070 - - - Degenerative 2 (10.0%) 0 (0.0%) 3 (15.0%) 
Prolapse 0 5 (25%) 9 (45.0%) 
Baseline echocardiographic data 
EF (%) 55.90 ± 9.61 59.85 ± 8.07 57.50 ± 9.64 0.394 - - - 
LVEDD (cm) 5.12 ± 0.34 5.53 ± 0.45 5.63 ± 0.56 0.002 0.008 0.001 0.496 
LVESD (cm) 3.76 ± 0.48 3.85 ± 0.45 4.02 ± 0.43 0.193 - - - 
LVEDV (ml) 125.35 ± 19.22 149.60 ± 28.06 156.85 ± 36.39 0.003 0.010 0.001 0.429 
LVESV (ml) 66.40 ± 13.13 67.80 ±11.31 71.35 ± 7.69 0.344 - - - 
LA diameter (mm) 40.2±11.1 36.2±10.4 40.1±9.1 0.377 - - - 
ESPAP (mmHg) 54.75 ± 10.06 52.55 ± 9.05 51.50 ± 9.34 0.547 - - - 
EF: ejection fraction; ESPAP: end-systolic pulmonary artery pressure; LVEDD: left ventricular end-diastolic 
diameter; LVESD: left ventricular end-systolic diameter; LVEDV: left ventricular end-diastolic volume; 
LVESV: left ventricular end-systolic volume. 
P1: comparison between group I and III  
P2: comparison between group II and III 
P3: comparison between group 1 and II 
Those 60 patients who fulfilled the criteria 
required for this study and completed six months 
of follow up were included into three groups 
according to the surgeons’ preference and mitral 
valve pathology: group I: included 20 patients who 
underwent MVR with complete excision of the 
subvalvular chordae and tips of papillary muscles 
(nonchordal group), group II: included 20 patients 
who underwent MVR with preservation of 
posterior chordo-papillary apparatus (posterior 
chordal), and group III: included 20 patients who 
underwent MVR with preservation of both 
posterior and anterior chordo-papillary apparatus 
(bilateral chordal group). The patients were 
followed clinically and echocardiography for 6 
months postoperatively. Study endpoints were 
changes in ejection fraction and left ventricle (LV) 
diameters, and secondary endpoints were the 
clinical outcomes, duration of mechanical 
ventilation, intensive care, and hospital stay.    
Surgical technique 
Mitral valve replacement was performed 
through a median sternotomy in all patients with 
moderate hypothermia and antegrade 
cardioplegia. Cold crystalloid cardioplegia was 
used in 49 patients (81.6%), warm blood 
cardioplegia in 8 patients (13.3%), and custodial 
was used in 3 patients (5%). Surgical exposure of 
the mitral valve was done through the left 
atriotomy, and the transseptal approach was used 
in 5 patients in group I (25%), 4 patients in group II 
(20%), and 3 patients in group III (15%).   
Once it is determined that the mitral valve not 
repairable due to excessive leaflet calcification, so 
mitral valve replacement was performed either 
with or without leaflet preservation. Group I had 
complete excision of both valve leaflets with the 
attached chordae and the tips of papillary 
muscles. Group II had posterior leaflets 
preservation; the anterior leaflets excised 2 to 3 







papillary muscle together with the attached 
chordae tendineae. The posterior leaflet may be 
retained completely along with the attached 
chordae tendineae. In this case, leaflet tissue 
folded up into the annulus by placing the valve 
sutures through the annulus and bringing them 
through the leading edge of the leaflet tissue. 
Otherwise, releasing incisions in order to divide 
the posterior leaflet into 2 to 5 chordo-papillary 
segments or small wedge resections of the leaflet 
was performed if the posterior leaflet was 
thickened and fibrotic to allow implantation of a 
larger valve. Group III had preservation of both 
anterior and posterior leaflets. Pledged sutures 
placed in such a manner that they pass from the 
atrium to the ventricle. 
Statistical Analysis 
The statistical analysis was performed using 
SPSS version 23 (IBM Corp- Chicago- IL, USA). The 
quantitative data were presented as mean, 
standard deviations, and ranges, and the 
qualitative variables were presented as numbers 
and percentages. The comparison between groups 
regarding qualitative data was performed using 
the Chi-square test and/or Fisher exact test when 
the expected frequency is less than 5. Quantitative 
data were compared using the One-Way ANOVA 
test, followed by post hoc analysis using the LSD 




Most patients in groups I and II had mixed 
mitral valve lesions, while pure mitral 
regurgitation predominated in group III. Native 
valve pathology and baseline echocardiographic 
data are shown in Table 2. 
Operative data: 
There was no difference in valve type (p= 
0.059) or size among groups (p= 0.697). 
Operative data are presented in Table 3. 
Postoperative outcomes 
Inotropic support was used in 17 patients in 
group I (85%), 10 patients in group II (50%), and 8 
patients in group III (40%). Postoperative 
outcomes are presented in Table 4. 
Figure 1: Changes in the left ventricular end-diastolic 
diameter in the three groups 
Postoperative echocardiographic data 
The MV prostheses for the 60 patients were all 
well-functioning with no valvular or para-valvular 
leakage. The results showed that the LV diastolic 
diameters were reduced significantly in the three 
groups in the immediate postoperative period 
(4.88 ±0.41, 5.26 ±0.43, and 5.18 ±0.56 cm in 
groups I, II and III, respectively, p= 0.039) and at 6 
months follow-up (5.40 ±0.34, 4.96 ± 0.43, and 
4.44 ± 0.55 cm in group I, II and III, respectively, 
p<0.001) (Figure 1). 
Figure 2: Changes in the left ventricular systolic 
diameter in three groups at different times 
Group I showed a significant increase in 
systolic diameters immediate postoperative 
period (3.83 ±0.47, 3.98 ±0.43, and 3.98 ±0.38 cm 
in group I, II, and III, respectively, p=0.435). At 6 
months follow up, a slight decline in systolic and 
diastolic diameters were noted. Group III showed 
a significant decrease in systolic diameters at the 
6 months follow-up (4.33 ±0.48, 3.58 ±0.43, and 






3.20 ±0.43 cm in group I, II and III, respectively, 
p<0.001) (Figure 2). 
The ejection fraction (LVEF) was reduced in the 
three groups in the early postoperative period 
(47.58 ±8.92, 52.05 ±10.51, and 49.80 ±8.72 % in 
group I, II and III, respectively, p= 0.348). In group 
I, there was progressive deterioration in LVEF, 
while in group II, the LV function maintained a 
steady course and failed to improve. In group III, 
gradual and remarkable improvements were 
noticed to reach preoperative values at 6-month 
studies (45.32 ±9.78, 56.79 ±10.14, and 56.60 
±11.68 % in group I, II and III respectively, 
p<0.001) (Figure 3). 
Figure 3: Ejection fraction in three groups at different 
times. 
Discussion 
Many studies were published and revealed 
that the total leaflet preservation was superior to 
the standard MVR method [12, 13]. Currently, 
posterior leaflet preservation is the commonly 
used approach. Despite the good results achieved 
by the total preservation technique, the technique 
is more demanding and not routinely used by 
many surgeons [14, 15]. 
In our study, patients who had subvalvular 
apparatus, preservation had longer cross-clamp 
times and total bypass time. Patients in the 
preservation groups had unsuccessful trials of 
repair before undergoing replacement, and this 
may explain the longer cross-clamp times. Other 
studies reported the same findings [16, 17]. 
The implanted prostheses in the three groups 
were comparable, and the mean valve size was 
29.4 ± 1.79 in group I, 29.3 ± 1.97 in group II, and 
28.8 ± 1.82 in group III. An argument against the 
preservation of the anterior leaflet was that only 
undersized valve prosthesis could be implanted. 
However, in our study, there was an insignificant 
difference between bilateral and posterior 
preservation groups, suggesting that preservation 
of the anterior mitral leaflet did not preclude 
implantation of a large prosthesis. Garcia-Fuster 
and colleagues reported similar prostheses sizes 
implanted [18]. Our results are in agreement with 
Zakai and associates who reported insignificant 
differences in the implanted prostheses sizes 
between no preservation and total preservation 
group [19]. 
In our study, we reported two patients in the 
total chordal group who had mechanical 
prosthesis insertion, and the limited movement of 
the leaflets was observed intra-operatively and 
was fixed immediately with rotating the valve to a 
position that allowed free smooth movement of 
both leaflets. We observed that patients in the 
preservation groups had shorter ventilation time 
and ICU and hospital stay. This can be explained by 
a lesser need for inotropes.
Table 3: Comparison of the operative data, valve size, and type used in the three groups. (Continuous variables are 
presented as mean± SD and categorical data as number and percent) 
Group I (n=20) Group II (n=20) Group III (n=20) P-value P1 P2 P3 
Mechanical valve 20 (100.0%) 19 (95.0%) 15 (80.0%) 0.059 - - - 
Cross-clamp time (mins) 58.50 ± 6.24 57.70 ± 6.45 63.30 ± 4.45 0.007 0.663 0.011 0.003 
Total bypass time (mins) 72.80 ± 6.88 70.80 ± 4.94 82.05 ± 5.88 <0.001 0.292 <0.001 <0.001 
P1: comparison between group I and III  
P2: comparison between group II and III 






Table 4: Comparison of the early postoperative variables among groups. (Continuous variables are presented as mean± 
SD and categorical variables as number and percent) 
Group I (n=20) Group II (n=20) Group III(n=20) P-value P1 P2 P3 
MV period 24.10 ± 6.61 16.80 ± 5.97 15.80 ± 5.24 <0.001 0.000 0.000 0.598 
ICU stay 78.65 ± 15.32 65.40 ± 14.21 60.20 ± 12.58 <0.001 0.004 0.000 0.248 
Low CO syndrome 9 (45.0%) 6 (30.0%) 3 (15.0%) 0.117 - - - 
Inotropic support 17 (85.0%) 10 (50.0%) 8 (40.0%) 0.010 0.018 0.003 0.525 
Stroke 1 (5.0%) 1 (5.0%) 0 (0.0%) 0.596 - - - 
Pacemaker  4(20.0%) 3 (15.0%) 2 (10.0%) 0.676 
Re-exploration 4 (20.0%) 2 (10.0%) 2 (10.0%) 0.562 - - - 
Mediastinitis 1 (5.0%) 1 (5.0%) 1 (5.0%) ˃0.99 - - - 
Ventilation >48 H 9 (45.0%) 5 (25.0%) 2 (10.0%) 0.043 0.184 0.013 0.211 
Mortality 2 (10.0%) 1 (5.0%) 0 (0.0%) 0.349 - - - 
Hospital stays 19.30 ± 6.42 16.20 ± 2.78 15.00 ± 2.97 0.009 0.029 0.003 0.391 
CO: cardiac output; ICU: intensive care unit; MV: mechanical ventilation 
P1: comparison between group I and III  
P2: comparison between group II and III 
P3: comparison between group 1 and II 
The preoperative studies showed patients in 
the preservation group had greater diameters and 
volumes, which had significant and gradual 
remodeling at discharge and later studies. In the 
non-preservation group, there was an initial 
regression in LVEDD with a significant increase in 
the LVESD. At later follow-ups, gradual raises in 
both systolic and diastolic volumes and diameters 
were noted. Kayagioglu and colleagues reported 
that the LVEDD and LVESD decreased in the 
preservation group and increased in the 
nonchordal group postoperatively, but the 
changes were insignificant [20]. 
By analysis of variance, the degree of 
reduction was more in bileaflet preservation 
group than the posterior preservation group. In 
the partial preservation group, immediate 
reductions were noted in LVEDV. At later studies, 
a steady course was noted with a slight decline in 
systolic and diastolic diameters. Yun and 
associates suggested that preserving all 
subvalvular apparatus resulted in more reductions 
in the LVESV and LVEDV with more favorable LV 
geometry [7]. 
In our study, there was a significant reduction 
in the LVEF immediately after surgery in the three 
groups. Total resection of chordae was associated 
with further reductions at 6 months follow-up. In 
the meta-analysis by Sa and colleagues, they 
concluded that there was more incidence of 
postoperative low cardiac output syndrome due 
to lower LVEF in the resection group than in the 
preservation group [21]. 
In our study, we reported significant 
reductions after partial or total preservation of the 
mitral valve apparatus with a significant 
superiority of total preservation over partial 
preservation on the systolic LVEF at 6 months 
follow-up, which indicates the important effect of 
the anterior MV leaflet on the LV function. In the 
meta-analysis by Sa and colleagues, they failed to 
show any significant advantage of the total over 
posterior preservation. However, there are many 
limitations in this meta-analysis; only 2 studies 
were randomized while 6 studies were non-
randomized, even the randomized trials did not 
mention their mode of randomization and how 
blind they were; additionally, there was 
heterogeneity in the techniques of preservation of 
the anterior and/or the posterior leaflets which 
would influence the results [21]. 
Study limitations 
The limitations of the study include the sample 
size, which is not sufficient to detect the 





difference in clinical outcomes; however, the 
study identified the difference in the primary 
echocardiographic endpoints. Another limitation 
is the single-center experience, and generalization 
of the results may be an issue.  The patients were 
assigned to each group according to the surgeons’ 
preference and the feasibility of preservation; 
therefore, the measured and unmeasured 
patients’ characters may not be equally 
distributed, and the outcome may have been 
affected by other factors. 
Conclusion 
Preservation of the annulo-papillary continuity 
may preserve the left ventricular geometry and 
performance. Total preservation of chordae could 
be superior to partial preservation with better LV 
remodeling and improvement in the LV functions. 
Preservation of the anterior leaflet may have no 
effect on the choice of the prosthetic size, left 
ventricular outflow tract obstruction or 
interference with prosthetic leaflets motion. 
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